Tobira Therapeutics (TBRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,564 | -12,221 | -49,617 | -40,230 | -18,019 |
| Depreciation Amortization | 193 | 96 | 18,419 | 18,321 | 900 |
| Income taxes - deferred | N/A | N/A | -4,393 | -4,392 | N/A |
| Accounts payable and accrued liabilities | 2,147 | 1,403 | 2,523 | N/A | 2,239 |
| Other Working Capital | 1,092 | 851 | 2,915 | 501 | 1,620 |
| Other Operating Activity | 404 | -215 | -1,141 | 603 | -2,496 |
| Operating Cash Flow | $-21,728 | $-10,086 | $-31,294 | $-25,197 | $-15,756 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -39 | -31 | -31 |
| Net Acquisitions | N/A | N/A | 33,232 | 33,232 | 33,232 |
| Investing Cash Flow | $N/A | $N/A | $33,193 | $33,201 | $33,201 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 12,954 | 12,954 | 12,954 |
| Debt Repayment | -11 | -6 | -21 | -16 | -10 |
| Common Stock Issued | N/A | N/A | 41,421 | 41,504 | 26,826 |
| Financing Cash Flow | $-11 | $-6 | $54,354 | $54,442 | $39,770 |
| Beginning Cash Position | 62,431 | 62,431 | 6,178 | 6,178 | 6,178 |
| End Cash Position | 40,692 | 52,339 | 62,431 | 68,624 | 63,393 |
| Net Cash Flow | $-21,739 | $-10,092 | $56,253 | $62,446 | $57,215 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,728 | -10,086 | -31,294 | -25,197 | -15,756 |
| Capital Expenditure | 0 | 0 | -39 | -31 | -31 |
| Free Cash Flow | -21,728 | -10,086 | -31,333 | -25,228 | -15,787 |